Millennium Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $9K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $33K | Sell |
|
|||||
|
2021
Q4 | $77K | Sell |
|
|||||
|
2021
Q3 | $102K | Sell |
|
|||||
|
2021
Q2 | $834K | Buy |
|
|||||
|
2021
Q1 | $342K | Buy |
|
|||||
|
2020
Q4 | $138K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $3.68M | Buy |
|
|||||
|
2020
Q1 | $167K | Sell |
|
|||||
|
2019
Q4 | $206K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $11K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $33K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $66K | Sell |
|
|||||
|
2015
Q2 | $265K | Sell |
|
|||||
|
2015
Q1 | $272K | Sell |
|
|||||
|
2014
Q4 | $6.9M | Sell |
|
|||||
|
2014
Q3 | $6.41M | Sell |
|
|||||
|
2014
Q2 | $9.97M | Buy |
|
|||||
|
2014
Q1 | $12.2M | Buy |
|